ChitogenX Inc. (CHNXF)
CHNXF Stock Price Chart
Explore ChitogenX Inc. interactive price chart. Choose custom timeframes to analyze CHNXF price movements and trends.
CHNXF Company Profile
Discover essential business fundamentals and corporate details for ChitogenX Inc. (CHNXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
6 Oct 2020
Employees
—
Website
https://www.chitogenx.comCEO
Pierre Laurin B.Sc.Pharm.,
Description
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
CHNXF Financial Timeline
Browse a chronological timeline of ChitogenX Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Dec 2025
Earnings released on 3 Sept 2025
Earnings released on 29 Jul 2025
Earnings released on 7 Jul 2025
Earnings released on 22 Dec 2024
EPS came in at -$0.01 falling short of the estimated -$0.01 by -39.47%.
Earnings released on 27 Sept 2024
EPS came in at -$0.00 surpassing the estimated -$0.01 by +60.08%.
Earnings released on 27 May 2024
EPS came in at -$0.01 surpassing the estimated -$0.01 by +32.80%.
Earnings released on 30 Jan 2024
EPS came in at -$0.00 surpassing the estimated -$0.01 by +72.45%.
Earnings released on 2 Jan 2024
EPS came in at -$0.01 matching the estimated -$0.01.
Earnings released on 29 Sept 2023
EPS came in at -$0.01 surpassing the estimated -$0.02 by +50.00%.
Earnings released on 29 Jun 2023
EPS came in at -$0.02 matching the estimated -$0.02.
Earnings released on 31 May 2023
EPS came in at -$0.03 falling short of the estimated -$0.02 by -33.16%.
Earnings released on 28 Dec 2022
EPS came in at -$0.03 falling short of the estimated -$0.02 by -33.33%.
Earnings released on 28 Sept 2022
EPS came in at -$0.02 matching the estimated -$0.02.
Earnings released on 23 Jun 2022
EPS came in at -$0.02 .
Earnings released on 19 May 2022
EPS came in at -$0.02 surpassing the estimated -$0.02 by +18.60%.
Earnings released on 21 Dec 2021
EPS came in at -$0.06 falling short of the estimated -$0.03 by -100.00%.
Earnings released on 30 Sept 2021
EPS came in at -$0.03 matching the estimated -$0.03.
Earnings released on 29 Jun 2021
EPS came in at -$0.03 .
Earnings released on 31 May 2021
EPS came in at -$0.04 falling short of the estimated -$0.02 by -100.00%.
Earnings released on 17 Dec 2020
EPS came in at -$0.03 matching the estimated -$0.03.
Earnings released on 24 Sept 2020
EPS came in at -$0.02 .
CHNXF Stock Performance
Access detailed CHNXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.